眼科用粘弾性デバイス市場規模、シェア、成長分析、製品タイプ別、用途別、エンドユーザー別、地域別-産業予測、2025～2032年

眼科用粘弾性デバイスの世界市場規模は2023年に105億米ドルと評価され、2024年の117億2,000万米ドルから2032年には281億9,000万米ドルに成長し、予測期間（2025～2032年）のCAGRは11.6%で成長する展望です。

眼科用粘弾性デバイス（OVDs）市場は、白内障、緑内障、加齢黄斑変性などの眼疾患の有病率の上昇に後押しされて力強い成長を遂げています。低侵襲の眼科手術に対する需要の増加と粘弾性材料の配合の進歩が、この市場拡大の原動力となっています。OVDは手術の際、空間を確保し、組織を安定させ、視力低下を防ぐという重要な役割を果たします。世界の眼科手術の急増、医療へのアクセスの改善、眼疾患に対する意識の高まりにより、市場は成長すると見られています。さらに、特に複雑な眼科手術では、複数のシリンジを必要としない効率の良さから、粘度適応型OVDの採用が進んでいます。全体として、これらの要因が産業を前進させています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の展望
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と展望

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主要市場の考察

• 重要成功要因
• 競合の程度
• 主要投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

眼科用粘弾性デバイス市場規模：製品タイプ別&CAGR（2025～2032年）

• 市場概要
• 疎水性
• 親水性
• 組み合わせ

眼科用粘弾性デバイス市場規模：タイプ別&CAGR（2025～2032年）

• 市場概要
• 粘着性眼科用粘弾性物質
• 分散性眼科用粘弾性物質

眼科用粘弾性デバイス市場規模：成分別&CAGR（2025～2032年）

• 市場概要
• ヒアルロン酸ナトリウム
• コンドロイチン硫酸
• ヒドロキシプロピルメチルセルロース

眼科用粘弾性デバイス市場規模：用途別&CAGR（2025～2032年）

• 市場概要
• 白内障手術
• 角膜手術
• 緑内障手術
• 屈折矯正手術

眼科用粘弾性デバイス市場規模：エンドユーザー別&CAGR（2025～2032年）

• 市場概要
• 病院
• 外来手術センター
• 眼科クリニック

眼科用粘弾性デバイス市場規模：剤形タイプ別&CAGR（2025～2032年）

• 市場概要
• 使い捨て
• 多目的

眼科用粘弾性デバイス市場規模&CAGR（2025～2032年）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他の欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他のアジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他のラテンアメリカ
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他の中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主要市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

    主要企業プロファイル

    • Alcon（スイス）
    • Bausch+Lomb（Bausch Health）（米国）
    • Carl Zeiss Meditec AG（ドイツ）
    • Johnson & Johnson Vision（米国）
    • Rayner Intraocular Lenses Limited（英国）
    • Bohus BIoTech AB（スウェーデン）
    • Lifecore Biomedical LLC（米国）
    • Hoya Corporation（日本）
    • Santen Pharmaceutical Co., Ltd.（日本）
    • Croma-Pharma GmbH（オーストリア）
    • Eyekon Medical Inc.（米国）
    • RUMEX International Co.（米国）
    • Ziemer Ophthalmic Systems AG（スイス）
    • Ophtechnics Unlimited（インド）
    • Haohai Biological Technology（中国）
    • Amring Pharmaceutical Inc.（米国）
    • Truviz Ophthalmic（米国）
    • Cima Technology Inc.（米国）

結論と提言

Global Ophthalmic Viscoelastic Devices Market size was valued at USD 10.5 billion in 2023 and is poised to grow from USD 11.72 billion in 2024 to USD 28.19 billion by 2032, growing at a CAGR of 11.6% during the forecast period (2025-2032).

The ophthalmic viscoelastic devices (OVDs) market is experiencing robust growth fueled by the rising prevalence of eye disorders, including cataracts, glaucoma, and age-related macular degeneration. Increasing demand for minimally invasive eye surgeries, along with advancements in viscoelastic material formulations, is driving this expansion. OVDs play a vital role during surgeries by preserving space, stabilizing tissues, and preventing vision loss. With a surge in ophthalmic surgeries worldwide, improved access to care, and heightened awareness of ocular disorders, the market is set to thrive. Furthermore, the adoption of viscoadaptive OVDs is gaining traction, particularly in complex ocular procedures, due to their efficiency in reducing the need for multiple syringes. Overall, these factors are collectively propelling the industry forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ophthalmic Viscoelastic Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Ophthalmic Viscoelastic Devices Market Segments Analysis

The ophthalmic viscoelastic devices market is segmented into product type, application, end user and region. Based on product type, the market is segmented into cohesive ophthalmic viscoelastic and dispersive ophthalmic viscoelastic. Based on application, the market is segmented into cataract, glaucoma, corneal transplant and vitreoretinal surgery. Based on end user, the market is segmented into hospitals, ophthalmic clinics and others. Based on region, the market is segmented into North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa.

Driver of the Global Ophthalmic Viscoelastic Devices Market

The Global Ophthalmic Viscoelastic Devices market is being significantly propelled by the rising occurrence of various eye disorders, including cataracts, glaucoma, and age-related macular degeneration, which correlate closely with an aging demographic and changing lifestyle choices. These conditions frequently require surgical treatments, underscoring the importance of ophthalmic viscoelastic devices that safeguard the eye's sensitive tissues, preserve surgical space, and enhance the overall surgical experience. As the patient population seeking such interventions increases, there is a correspondingly higher demand for superior viscoelastic products, thereby driving the market's growth and presenting opportunities for innovation in this critical healthcare segment.

Restraints in the Global Ophthalmic Viscoelastic Devices Market

The Global Ophthalmic Viscoelastic Devices market faces a notable challenge due to the high costs associated with advanced devices that utilize innovative materials and improved biocompatibility. This elevated pricing poses a substantial obstacle for hospitals and clinics, particularly in emerging markets or areas with constrained healthcare budgets. As a result, patients in low and middle-income countries often encounter difficulties in accessing these premium products, primarily due to affordability concerns. Consequently, this situation restricts the overall market penetration of advanced ophthalmic viscoelastic devices in these regions, limiting their widespread adoption and use in vital eye care procedures.

Market Trends of the Global Ophthalmic Viscoelastic Devices Market

The Global Ophthalmic Viscoelastic Devices market is witnessing a significant trend towards the integration of artificial intelligence (AI) and digital technologies within surgical workflows. This innovation is enhancing preoperative planning, intraoperative guidance, and postoperative care, particularly in the application of viscoelastic devices. As AI-driven imaging and surgical assistance become more sophisticated, they offer improved precision and reduced risks during procedures, which in turn leads to better surgical outcomes. This synergy is driving increased adoption rates of viscoelastic devices that are compatible with advanced AI systems, positioning the market for robust growth as these technologies become standard in ophthalmic surgery.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Ophthalmic Viscoelastic Devices Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Hydrophobic
• Hydrophilic
• Combination

Global Ophthalmic Viscoelastic Devices Market Size by Type & CAGR (2025-2032)

• Market Overview
• Cohesive Ophthalmic Viscoelastic
• Dispersive Ophthalmic Viscoelastic

Global Ophthalmic Viscoelastic Devices Market Size by Composition & CAGR (2025-2032)

• Market Overview
• Sodium Hyaluronate
• Chondroitin Sulfate
• Hydroxypropyl Methylcellulose

Global Ophthalmic Viscoelastic Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Cataract Surgery
• Corneal Surgery
• Glaucoma Surgery
• Refractive Surgery

Global Ophthalmic Viscoelastic Devices Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Ophthalmic Clinics

Global Ophthalmic Viscoelastic Devices Market Size by Formulation Type & CAGR (2025-2032)

• Market Overview
• Single-Use
• Multi-Use

Global Ophthalmic Viscoelastic Devices Market Size & CAGR (2025-2032)

• North America (Product Type, Type, Composition, Application, End User, Formulation Type)
  • US
  • Canada
• Europe (Product Type, Type, Composition, Application, End User, Formulation Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Type, Composition, Application, End User, Formulation Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Type, Composition, Application, End User, Formulation Type)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Type, Composition, Application, End User, Formulation Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Alcon (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch + Lomb (Bausch Health) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carl Zeiss Meditec AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Vision (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rayner Intraocular Lenses Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bohus Biotech AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lifecore Biomedical LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hoya Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Santen Pharmaceutical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Croma-Pharma GmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eyekon Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RUMEX International Co. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ziemer Ophthalmic Systems AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ophtechnics Unlimited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haohai Biological Technology (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amring Pharmaceutical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Truviz Ophthalmic (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cima Technology Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations